Literature DB >> 11739383

Isolation and characterization of a novel class II histone deacetylase, HDAC10.

Denise D Fischer1, Richard Cai, Umesh Bhatia, Fred A M Asselbergs, Chuanzheng Song, Robert Terry, Nancy Trogani, Roland Widmer, Peter Atadja, Dalia Cohen.   

Abstract

A novel histone deacetylase, HDAC10, was isolated from a mixed tissue human cDNA library. HDAC10 was classified as a class II subfamily member based upon similarity to HDAC6. The genomic structure of HDAC10 was found to consist of 20 exons. HDAC10 has two sequence variants, HDAC10v1 and HDAC10v2, and two transcripts were detectable by Northern blot analysis. HDAC10v1 and HDAC10v2 were found to be identical through exon 17 but diverged after this exon. HDAC10v2 has an 82-bp alternate exon that generates a frameshift and shortens the sequence by 11 amino acids. In this study, the characterization of HDAC10v1 was performed. HDAC10v1 has an N-terminal catalytic domain, two putative C-terminal retinoblastoma protein binding domains, and a nuclear hormone receptor binding motif. The HDAC10v1 enzyme was found to be catalytically active based upon its ability to deacetylate a (3)H-acetylated histone H4 N-terminal peptide. Immunofluorescence detection of transfected HDAC10v1-FLAG indicated that the enzyme is a nuclear protein. Furthermore, coimmunoprecipitation experiments indicated that HDAC10v1 associated with HDAC2 and SMRT (silencing mediator for retinoid and thyroid hormone receptors). In addition, based upon the public data base, a single nucleotide polymorphism was found in the C terminus of HDAC10 which changes a Gly residue to Cys, suggesting that HDAC10 molecules containing these single nucleotide polymorphisms may be folded improperly. HDAC10 extends the HDAC superfamily and adds to a growing number of HDACs that have been found to have splice variants, suggesting that RNA processing may play a role in mediating the activity of HDACs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739383     DOI: 10.1074/jbc.M108055200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain.

Authors:  Zhihu Ding; Laura L Gillespie; Gary D Paterno
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 3.  Metabolic reprogramming by class I and II histone deacetylases.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Trends Endocrinol Metab       Date:  2012-10-09       Impact factor: 12.015

4.  Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.

Authors:  Thanaset Senawong; Valerie J Peterson; Dorina Avram; David M Shepherd; Roy A Frye; Saverio Minucci; Mark Leid
Journal:  J Biol Chem       Date:  2003-08-19       Impact factor: 5.157

5.  Pharmacogenomic approaches to asthma treatment.

Authors:  Sang-Heon Cho
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-19       Impact factor: 5.764

Review 6.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28

7.  Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.

Authors:  Guang Bai; Dong Wei; Shiping Zou; Ke Ren; Ronald Dubner
Journal:  Mol Pain       Date:  2010-09-07       Impact factor: 3.395

8.  Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

Authors:  David Waltregny; Laurence De Leval; Wendy Glénisson; Siv Ly Tran; Brian J North; Akeila Bellahcène; Ulrich Weidle; Eric Verdin; Vincent Castronovo
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Developmental expression of histone deacetylase 11 in the murine brain.

Authors:  Hedi Liu; Qichen Hu; Amanda Kaufman; A Joseph D'Ercole; Ping Ye
Journal:  J Neurosci Res       Date:  2008-02-15       Impact factor: 4.164

10.  In vitro nuclear interactome of the HIV-1 Tat protein.

Authors:  Virginie W Gautier; Lili Gu; Niaobh O'Donoghue; Stephen Pennington; Noreen Sheehy; William W Hall
Journal:  Retrovirology       Date:  2009-05-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.